lobbying_activities: 1838246

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1838246	5832e915-63cb-4ef8-8dd7-885ae6de395a	2T	BLOOM STRATEGIC COUNSEL	401036920	PFIZER INC.	2016	second_quarter	LBR	The merger between Pfizer and Allergan, and related competition issues.	SENATE	60000		0	1	2016-07-07T14:43:22.077000-04:00